InvestorsHub Logo
Followers 54
Posts 4438
Boards Moderated 0
Alias Born 08/21/2015

Re: excelsiorvision post# 20569

Monday, 04/24/2017 4:29:13 PM

Monday, April 24, 2017 4:29:13 PM

Post# of 73515
Otiko can't sue Keough for slander, defamation, etc. for contents of a Federal Lawsuit.

No excessive shorting is happening with this ticker. The daily reports indicate typical averages for penny stocks.

http://otcshortreport.com/?index=VDRM&action=view

There is no record of a Kasten trade halt by the SEC. The company may have chosen to cease trading while they work through their transition with Dakota Life Sciences. Keough did note the merger was at risk of dissolution as a result of Otiko's actions, and institutional investor fears related to Otiko's actions.

Fundamentals are horrible here. They may have to raise the Authorized so they can sell more shares to cover legal fees. The A/S is only 60M above the O/S. They reported a Going Concern with a delinquent Note in the 200-300K area. This is no "boilerplate" verbiage. It has a real number. Some tickers express NO going concern. Otiko owes ViaDerma 300k according to the latest financial report. That number is in the A/R line.

Now Otiko is facing the possibility of an injunction to prevent him from selling products based on IP owned by Keough.

Otiko can and likely will counter-sue for slander, defamation, amongst other charges. Keogh will likely be on the hook not just for the fees of his attorney(s), but the legal costs VDRM 'might' have to incur as well.

However, as you see, KAST was halted on 4/18 - www.otcmarkets.com/stock/KAST/chart

Patents were abandoned years ago.

You really think that Keogh had no knowledge of any of this over the past few years until just a few weeks ago? Now, that KAST is failing, he is throwing fire on VDRM with a frivolous lawsuit. It won't stick.

VDRM is being heavily shorted right now and weak hands are falling for it.

Fundamentals are strong here. As soon as the talked about updates come online, this stock will skyrocket way past previous highs a couple of months ago.

Technical charts show it being grossly oversold and today seems like one of the last shots to spook weak hands into selling too. The gap has been filled and RSI is super low.

Only up, up, up to where we should be going to. Stay patient. Great days to come soon...